/Companies

TechsoMed

3 known investors

Find your way into TechsoMed

Sign up to see every warm intro you have to TechsoMed

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the TechsoMed team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

TechsoMed develops BioTrace, an FDA-cleared software platform for image-guided minimally invasive cancer therapy that uses AI to provide real-time 3D visualization, tumor margin control, needle path planning, and post-ablation tissue response prediction. The system serves physicians performing ablation procedures, compressing imaging frames into a single interface for full-cycle ablation management.

Founders & leadership

YA
Yossi Abu
DMDasy Mandel
Dasy Mandel
NENitzan Even
Nitzan Even
YZYogev Zohar
Yogev Zohar
DFDubi Finklshtein
Dubi Finklshtein

Investors · 3

Funding

SEC filings, press & company announcements

$7M disclosed across 1 round · 2021

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does TechsoMed do?
TechsoMed develops BioTrace, an FDA-cleared software platform for image-guided minimally invasive cancer therapy that uses AI to provide real-time 3D visualization, tumor margin control, needle path planning, and post-ablation tissue response prediction. The system serves physicians performing ablation procedures, compressing imaging frames into a single interface for full-cycle ablation management.
Who are TechsoMed's investors?
TechsoMed's investors include NextLeap Ventures, Axil Capital, Helios Climate Ventures.
How much funding has TechsoMed raised?
TechsoMed has disclosed $7M raised across 1 round.